EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy

Hani Ali-Ghosh, Jason Kho, Fotios Leventis, Sanjay Asopa, Geoffrey Tsang, Sunil K Ohri iD

Journal of Cardiovascular Development and Disease · 08.06.2026 · 13 (6) · 254

DOI: 10.3390/jcdd13060254 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 08.06.2026. Verfasst von Hani Ali-Ghosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinoid heart disease is a progressive right-sided valvulopathy caused by serotonin and other vasoactive mediators released by metastatic neuroendocrine tumours. As oncological therapies have extended survival, cardiac disease has become a leading determinant of mortality. Operative mortality has decreased to 5–6% in contemporary high-volume centres, and long-term survival appears increasingly determined by tumour biology rather than cardiac disease when surgery is appropriately timed. The principal determinant of operative outcome is preoperative right ventricular function; symptom-based referral alone is insufficient because many patients remain compensated until ventricular dysfunction is advanced. This review synthesises the evidence on surgical timing, operative strategy, prosthesis selection, perioperative endocrine management, and emerging transcatheter options. Tricuspid valve replacement is required in the majority of patients, with concomitant pulmonary valve replacement advocated where concurrent disease is present. Bioprosthetic valves are preferred. Continuous perioperative octreotide infusion has substantially reduced the incidence of carcinoid crisis. Structured multidisciplinary decision-making integrating echocardiographic surveillance, biomarker monitoring, and oncological status assessment is essential.

Schlagwörter

Stichwörter der Autor:innen

carcinoid heart diseasecarcinoid syndromeneuroendocrine tumourpulmonary valve replacementright ventricular functionsurgical timingtricuspid valve replacement

Autor:innen und Institutionen

  • Department of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.

ORCID-Profile: Sunil K Ohri

Zitieren

APA

Ali-Ghosh, H., Kho, J., Leventis, F., Asopa, S., Tsang, G., & Ohri, S. K. (2026). Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy. Journal of Cardiovascular Development and Disease, 13(6), 254. https://doi.org/10.3390/jcdd13060254

Vancouver

Ali-Ghosh H, Kho J, Leventis F, Asopa S, Tsang G, Ohri SK. Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy. Journal of Cardiovascular Development and Disease. 2026;13(6):254. doi:10.3390/jcdd13060254

BibTeX
@article{AliGhosh2026,
  author = {Ali-Ghosh, Hani and Kho, Jason and Leventis, Fotios and Asopa, Sanjay and Tsang, Geoffrey and Ohri, Sunil K},
  title = {Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {254},
  doi = {10.3390/jcdd13060254}
}
Kostenlos starten →